Treating methicillin-resistant Staphylococcus aureus infections with compounded vancomycin preparations.
Methicillin-Resistant Staphylococcus aureus infections have been an ongoing problem with institutions. Unfortunately, the problem has crossed over into the community setting. Drug resistance develops so rapidly that it is difficult for drug manufacturers to develop new treatment options in a timely manner. Compounding pharmacists can help physicians treat their Methicillin-Resistant Staphylococcus aureus patients by assisting them in developing new dosage forms or therapies to treat these difficult infections and providing patient counseling to prevent infection.